Skip to main content
. 2020 Aug 28;26(32):4817–4832. doi: 10.3748/wjg.v26.i32.4817

Table 7.

Frequency of detected human leukocyte antigen class I alleles and the class II alleles in patients with cancer and ulcer and in the control groups, n (%)

HLA-A Allele frequency HLA-B Allele frequency HLA-DRB1 Allele frequency HLA-DQA1 Allele frequency HLA-DQB1 Allele frequency
Alleles Cases (n = 94) Control (n = 86) Alleles Cases (n = 94) Control (n = 86) Alleles Cases (n = 94) Control (n = 86) Alleles Cases (n = 94) Control (n = 86) Alleles Cases (n = 94) Control (n = 86)
01 22 (11.4) 24 (13.9) 07 18 (9.5) 22 (12.8) 01 14 (7.4) 8 (4.6) 01 76 (40) 30 (17.4) 02 20 (10.6) 26 (15.1)
02 52 (27.6) 38 (22) 08 6 (3.2) 6 (3.5) 03 10 (5.3) 10 (5.8) 02 20 (10.6) 20 (11.6) 03 42 (23) 64 (37.2)
03 14 (7.4) 20 (11.6) 13 6 (3.2) 4 (2.3) 04 16 (8.5) 22 (12.7) 03 12 (6.4) 22 (12.8) 04 26 (13.8) 28 (16.2)
11 18 (9.5) 18 (10.4) 14 6 (3.2) 4 (2.3) 07 10 (5.3) 20 (11.6) 04 16 (8.5) 20 (11.6) 05 48 (25.5) 34 (19.8)
23 10 (5.3) 4 (2.3) 15 2 (1) 6 (3.5) 08 4 (2.1) 6 (3.5) 05 28 (14.9) 54 (31.4) 06 52 (27.6) 20 (11.6)
24 26 (13.8) 24 (13.9) 18 10 (5.3) 10 (5.8) 10 6 (3.2) 4 (2.3) 06 36 (19.1) 26 (15.1)
25 0 (0) 2 (1.1) 27 6 (3.2) 4 (2.3) 11 34 (18) 42 (24.4)
26 4 (2.1) 4 (2.3) 35 40 (21.3) 26 (15.1) 12 6 (3.2) 2 (1.2)
29 8 (4.2) 8 (4.6) 37 4 (2.1) 0 (0) 13 36 (19) 24 (14)
30 4 (2.1) 6 (3.4) 38 8 (4.2) 2 (1.2) 14 18 (9.5) 8 (4.6)
31 2 (1) 4 (2.3) 39 0 (0) 4 (2.3) 15 28 (14.9) 22 (12.8)
32 16 (8.5) 10 (5.8) 40 6 (3.2) 6 (3.5) 16 6 (3.2) 4 (2.3)
33 6 (3.1) 4 (2.3) 41 4 (2.1) 2 (1.2)
68 4 (2.1) 6 (3.4) 44 8 (4.2) 14 (8.1)
69 2 (1) 0 (0) 45 0 (0) 2 (1.2)
48 2 (1) 2 (1.2)
49 6 (3.2) 4 (2.3)
50 0 (0) 10 (5.8)
51 24 (12) 30 (17.4)
52 14 (7.4) 2 (1.2)
53 0 (0) 2 (1.2)
54 2 (1) 0 (0)
55 6 (3.2) 8 (4.6)
57 2 (1) 2 (1.2)
58 8 (4.2) 0 (0)
78 0 (0) 0 (0)

HLA: Human leukocyte antigen.